Interna Therapeutics Partners with Daiichi Sankyo to Enhance MNM Technology for Targeted Drug Delivery Interna Therapeutics has formed a research collaboration with Daiichi Sankyo to enhance drug delivery systems utilizing MNM technology. This partnership aims to improve the efficacy of targeted therapies.

Interna Therapeutics Partners with Daiichi Sankyo to Enhance MNM Technology for Targeted Drug Delivery #Israel #Daiichi_Sankyo #Petach_Tikva #Interna_Therapeutics #MNM_Technology